The Company enters 2026 with Multiple Phase 2 Catalysts collectively representing ~$8 billion in potential market ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
About Cadence Design Systems Inc. Cadence Design Systems, Inc. engages in the provision of design and development of integrated circuits and electronic devices. It operates through the following ...
DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...
Background Inflammatory bowel disease (IBD) patients in China exhibit critically low levels of physical activity, yet evidence for telemedicine-based aerobic exercise interventions remains scarce, ...
The analyses of progression-free survival (PFS) and overall survival (OS) remain on track for late Q1 2026 in the ongoing Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback